Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study

Background  The incidence of proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease (GERD) has been increasing. While surgical intervention with Laparoscopic Nissen Fundoplication remains the gold standard, less invasive anti-reflux interventions are desired. We have developed a mini...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Haruhiro, Tanabe, Mayo, de Santiago, Enrique Rodríguez, Abad, Mary Raina Angeli, Shimamura, Yuto, Fujiyoshi, Yusuke, Ueno, Akiko, Sumi, Kazuya, Tomida, Hideomi, Iwaya, Yugo, Ikeda, Haruo, Onimaru, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: © Georg Thieme Verlag KG 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976329/
https://www.ncbi.nlm.nih.gov/pubmed/32010745
http://dx.doi.org/10.1055/a-1031-9436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976329/
https://www.ncbi.nlm.nih.gov/pubmed/32010745
http://dx.doi.org/10.1055/a-1031-9436

Ejemplares similares